These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26206948)

  • 1. Improved outcomes associated with hematopoietic stem cell transplantation for patients with juvenile myelomonocytic leukemia.
    Zhao Q; Mahadeo KM; Kapoor N; Abdel-Azim H
    Blood; 2015 Jul; 126(4):561-2. PubMed ID: 26206948
    [No Abstract]   [Full Text] [Related]  

  • 2. Disappearance of minimal residual disease after the early withdrawal of immunosuppressants in a patient with juvenile myelomonocytic leukemia.
    Yanagisawa R; Matsuda K; Sakashita K; Nakazawa Y; Tanaka M; Saito S; Yoshikawa K; Kamijo T; Shiohara M; Koike K
    Pediatr Blood Cancer; 2011 Mar; 56(3):501-2. PubMed ID: 21225940
    [No Abstract]   [Full Text] [Related]  

  • 3. 6-Mercaptopurine to Induce Remission Despite Graft Failure Post Hematopoietic Cell Transplantation for Juvenile Myelomonocytic Leukemia.
    Hashem H
    J Pediatr Hematol Oncol; 2022 Mar; 44(2):67. PubMed ID: 34654760
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical Study on Treatment of Juvenile Myelomonocytic Leukemia with Haploidentical-Hematopoietic Stem Cell Transplantation].
    Ding L; Zhu H; Han DM; Wang ZD; Zheng XL; Dong L; Yan HM; Liu J; Zhu L; Xue M; Guo ZK; Wang HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1524-1527. PubMed ID: 29070137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation for juvenile myelomonocytic leukemia: a retrospective study of 30 children treated with a regimen of busulfan, fludarabine, and melphalan.
    Yabe M; Ohtsuka Y; Watanabe K; Inagaki J; Yoshida N; Sakashita K; Kakuda H; Yabe H; Kurosawa H; Kudo K; Manabe A;
    Int J Hematol; 2015 Feb; 101(2):184-90. PubMed ID: 25504334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of immunological interventions for mixed chimerism following allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia.
    Inagaki J; Fukano R; Nishikawa T; Nakashima K; Sawa D; Ito N; Okamura J
    Pediatr Blood Cancer; 2013 Jan; 60(1):116-20. PubMed ID: 22847790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of both cords nine months post double cord blood transplantation for juvenile myelomonocytic leukaemia.
    Yadav SP; Dhingra N; Saxena R; Sachdeva A
    Hematol Oncol Stem Cell Ther; 2013 Jun; 6(2):79-80. PubMed ID: 23669498
    [No Abstract]   [Full Text] [Related]  

  • 8. [Allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia and juvenile myelomonocytic leukemia].
    Shao Q; Wang ZD; Zheng XL; Dong L; Han DM; Yan HM; Wang HX; Duan LN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1058-62. PubMed ID: 25130828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular assessment of pretransplant chemotherapy in the treatment of juvenile myelomonocytic leukemia.
    Hecht A; Meyer J; Chehab FF; White KL; Magruder K; Dvorak CC; Loh ML; Stieglitz E
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27948. PubMed ID: 31347788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile myelomonocytic leukemia.
    Satwani P; Kahn J; Dvorak CC
    Pediatr Clin North Am; 2015 Feb; 62(1):95-106. PubMed ID: 25435114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of disease recurrence after allogeneic hematopoietic stem cell transplantation in children with juvenile myelomonocytic leukemia: a great challenge still to be won.
    Locatelli F; Lucarelli B
    Pediatr Blood Cancer; 2013 Jan; 60(1):1-2. PubMed ID: 22976832
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful second unrelated cord blood transplantation in a child with juvenile myelomonocytic leukemia.
    Alsultan A; Jarrar M; Mushaqbah W; Al-Sudairy R; Jawdat D
    Pediatr Transplant; 2014 Sep; 18(6):651-2. PubMed ID: 24978300
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary Graft Failure but Treatment Success: A Case of Reversion to Heterozygosity After Allogeneic Hematopoietic Cell Transplantation With Autologous Hematopoietic Recovery in a Child With CBL-related Juvenile Myelomonocytic Leukemia.
    Oshrine B
    J Pediatr Hematol Oncol; 2021 Apr; 43(3):e426-e428. PubMed ID: 32032248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft versus leukemia effect against juvenile myelomonocytic leukemia after unrelated cord blood transplantation.
    Tanoshima R; Goto H; Yanagimachi M; Kajiwara R; Kuroki F; Yokota S
    Pediatr Blood Cancer; 2008 Mar; 50(3):665-7. PubMed ID: 17437289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haploidentical non-myeloablative stem cell transplantation as salvage for graft failure in a patient with juvenile myelomonocytic leukemia.
    Perini GF; Kerbauy FR; Fernandes JF; Santos FP; Torres MA; Ribeiro AA; Hamerschlak N
    Pediatr Blood Cancer; 2011 Dec; 57(6):1084. PubMed ID: 21748848
    [No Abstract]   [Full Text] [Related]  

  • 16. Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group.
    Cseh A; Niemeyer CM; Yoshimi A; Dworzak M; Hasle H; van den Heuvel-Eibrink MM; Locatelli F; Masetti R; Schmugge M; Groß-Wieltsch U; Candás A; Kulozik AE; Olcay L; Suttorp M; Furlan I; Strahm B; Flotho C
    Blood; 2015 Apr; 125(14):2311-3. PubMed ID: 25838281
    [No Abstract]   [Full Text] [Related]  

  • 17. [Molecular mechanism and treatment of juvenile myelomonocytic leukemia (JMML)].
    Manabe A
    Rinsho Ketsueki; 2012 Aug; 53(8):729-33. PubMed ID: 22975811
    [No Abstract]   [Full Text] [Related]  

  • 18. Image Gallery: Juvenile cutaneous chronic graft-versus-host disease presenting as bullous pemphigoid.
    Haber R; Bourrat E; Derache AF; Rivet J; Bagot M; Dalle JH; Bouaziz JD
    Br J Dermatol; 2017 Sep; 177(3):e69. PubMed ID: 28940263
    [No Abstract]   [Full Text] [Related]  

  • 19. Sustained responses after clofarabine-based sequential allogeneic stem cell transplantation in children with high-risk, relapse and/or refractory acute myeloid leukemia or juvenile myelomonocytic leukemia: a study on behalf of the French society of bone marrow transplantation or cell therapy (SFGM-TC).
    Grain A; Sirvent A; Strullu M; Françoise M; Mohty M; Guillaume T; Chevallier P; Rialland F
    Leuk Lymphoma; 2016 Dec; 57(12):2937-2941. PubMed ID: 27184944
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies.
    Olsson RF; Logan BR; Chaudhury S; Zhu X; Akpek G; Bolwell BJ; Bredeson CN; Dvorak CC; Gupta V; Ho VT; Lazarus HM; Marks DI; Ringdén OT; Pasquini MC; Schriber JR; Cooke KR
    Leukemia; 2015 Aug; 29(8):1754-62. PubMed ID: 25772027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.